STPharmLtd 

₩99,100
0
+₩0+0% Hari ini

Statistik

Harga Tertinggi Hari
101,900
Harga Terendah Hari
97,700
52M Tertinggi
120,800
52M Terendah
59,900
Volum
196,318
Volum Purata
509,284
Kapasiti Pasaran
2.14T
Nisbah P/E
-
Pendapatan Dividen
0.5%
Dividen
494.51

Akan Datang

Dividen

0.5%Pendapatan Dividen
Pertumbuhan 10T
N/A
Pertumbuhan 5T
N/A
Pertumbuhan 3T
N/A
Pertumbuhan 1T
N/A

Pendapatan

25JulDijangka
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
309.48
366.88
424.27
481.67
EPS yang dijangka
N/A
EPS sebenar
N/A

Orang Lain Juga Mengikuti

Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti 237690.KQ. Ini bukan cadangan pelaburan.

Peserta

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.

Mengenai

ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.
Show more...
CEO
Mr. Geun-Jo Im Ph.D.
Pekerja
566
Negara
KR
ISIN
KR7237690003

Penyenaraian